| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/12/2005 | CN1562357A Medication use for external application of glucose-insulin-potassium polarization liquid for curing trauma and burn |
| 01/12/2005 | CN1562326A Compound skins lintement of Chinese traditional medicine |
| 01/12/2005 | CN1562324A External remedy for curing eczema |
| 01/12/2005 | CN1562320A Preparation of Chinese traditional medicine for curing skin disease |
| 01/12/2005 | CN1562319A Medication for curing skin disease |
| 01/12/2005 | CN1562318A Ointment for curing fracture and preparation method |
| 01/12/2005 | CN1562290A Combination of medication for curing burn and scald and preparation method |
| 01/12/2005 | CN1562283A Medicinal use of spanish moss of Chinese traditional medicine |
| 01/12/2005 | CN1562282A Clinical medication for healing wound without need of sewing it and preparation method |
| 01/12/2005 | CN1562277A Medication for treating ulcer of lower limb of patients of skin disease and diabetic, and preparation method |
| 01/12/2005 | CN1562258A Three-oxygen therapy ointment |
| 01/12/2005 | CN1562231A External remedy 'Jiaochoujing' for treating Hang Kong foot |
| 01/12/2005 | CN1562227A Combination of Chinese tradidional medicine for nourishing skin and health preservation, and preparation method |
| 01/12/2005 | CN1562218A Medication combination of compound tea tree oil for preventing or curing inflammation of human genital tract |
| 01/12/2005 | CN1562196A Medicine efficacious for burn and preparation method |
| 01/12/2005 | CN1562169A Chinese medica preparation for treating dermatitis, eczema, herpes and herpes zoster |
| 01/12/2005 | CN1562168A Compound preparation of cooling blood and promoting blood flow for curing psoriasis, and preparation method |
| 01/12/2005 | CN1562164A External drug of the Chinese traditional medicine for treating acne |
| 01/12/2005 | CN1562154A Specific burn and scald medicine and preparing method |
| 01/12/2005 | CN1562140A Chinese-western combined medicine for treating burn and scald and other external wound |
| 01/12/2005 | CN1562138A Medicine for treating pointed condyloma with pure Chinese medicine |
| 01/12/2005 | CN1562124A Wart removing liquid and using method |
| 01/12/2005 | CN1562123A Medicine for treating burn and scald |
| 01/12/2005 | CN1562121A Medicine for treating canker and preparing method |
| 01/12/2005 | CN1562110A External paste for treating burn |
| 01/12/2005 | CN1562109A Multifunction health therapeutic external use liquid |
| 01/12/2005 | CN1562107A Scar-free brun medicinal agent |
| 01/12/2005 | CN1562106A Paste for treating shank ulcer and bedsore |
| 01/12/2005 | CN1562099A Chinese medicine for treating white hair and its preparing method |
| 01/12/2005 | CN1562080A Broad spectrum bacteriostat and sterilizing of silicate based angstrom silver ion nano porous composite mateiral |
| 01/12/2005 | CN1562079A Broad spectrum bacteriostat and sterilizing of silver ion nano porous material |
| 01/12/2005 | CN1562078A Medicine for treating beri-beri |
| 01/12/2005 | CN1562077A Eliminating stasis and tissue generation toxic removing pill |
| 01/12/2005 | CN1562069A Use of C-ski gene and its polypeptide in preparing medicine for improving tissue repairing and reducing scar formation |
| 01/12/2005 | CN1562003A Compound metrinizole cream |
| 01/12/2005 | CN1562002A Novel anti-biological cell free redical oxidation injury mixture |
| 01/12/2005 | CN1184208C Substituted benzimidazoles and their prepn. and use |
| 01/12/2005 | CN1184200C Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same |
| 01/12/2005 | CN1183953C Medicine for clearnig away heat and toxic matter, promoting diuresis and stopping itching |
| 01/12/2005 | CN1183950C Chinese herbal medicine preparation for treating burns |
| 01/12/2005 | CN1183940C Ointment for curnig leukoplakia vulvae and its preparing method |
| 01/12/2005 | CN1183939C Curing medicine for wound |
| 01/12/2005 | CN1183934C Disinfectant |
| 01/12/2005 | CN1183925C Externally-used paste for curing burn, scald and electric shock wound |
| 01/12/2005 | CN1183917C Dermatosis treating ointment |
| 01/12/2005 | CN1183912C Medicine for relieving itching and detumescence |
| 01/12/2005 | CN1183899C Skin protection spot-removing cream and preparation method thereof |
| 01/12/2005 | CN1183894C Composition for external use |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841571 Compounds useful as reversible inhibitors of cysteine proteases |
| 01/11/2005 | US6841567 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/11/2005 | US6841564 Tri-aryl-substituted-ethane PDE4 inhibitors |
| 01/11/2005 | US6841550 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 01/11/2005 | US6841177 Pharmacological activities of curcuma longa extracts |
| 01/11/2005 | US6841162 Cosmetic or dermatological composition contacting at least one natural or recombinant spider silk or an analog |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2269128C Piperazino derivatives as neurokinin antagonists |
| 01/11/2005 | CA2248235C Use of honey as an agent to reduce the adhesion of microorganisms |
| 01/11/2005 | CA2241244C Use of inhibitors of the activity of retinoic acid for treating sensitive skin and/or acute damage induced by uv radiation |
| 01/06/2005 | WO2005001732A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
| 01/06/2005 | WO2005001469A1 Method of acidic polysaccharide analysis and kit for the analysis |
| 01/06/2005 | WO2005000843A2 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 01/06/2005 | WO2005000337A1 Compositions and methods for treatment of rosacea |
| 01/06/2005 | WO2005000328A1 Compositions based on plant ash for the treatment of skin diseases |
| 01/06/2005 | WO2005000321A1 Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas |
| 01/06/2005 | WO2005000300A1 Substituted 5-membered ring compounds and their use |
| 01/06/2005 | WO2005000287A1 External preparation for athlete's foot treatment |
| 01/06/2005 | WO2005000266A2 Liposomal formulations comprising a combination of two or more active agents |
| 01/06/2005 | WO2005000231A2 Il-8 receptor antagonists |
| 01/06/2005 | WO2004096862A3 Improved extration and purification method for cereal beta (1-3) beta (1-4) glucan |
| 01/06/2005 | WO2004073595A3 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 01/06/2005 | WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/06/2005 | US20050004360 Compounds and methods for modulation of estrogen receptors |
| 01/06/2005 | US20050004274 Ester with one or more triblock copolymers having rigid and elastic sections; mineral oil free; vehicles for topical materials |
| 01/06/2005 | US20050004202 Such as 3-[1-(3-methoxypropyl )-1H-indazol-3-yl]-4-[1-(3-pyridinyl )-1H-indol-3-yl]-1H-pyrrole-2,5-dione; protein kinase C and/or glycogen synthase kinase-3 diseases |
| 01/06/2005 | US20050004180 Conditions mediated by beta chemokine receptor 2, monocyte chemotactic protein 1 and/or their interaction; such as 4-acetyl-5-cyclohexyl-3-amino-1-(4-methylphenyl)-1,5-dihydro-2H-pyrrol-2-one |
| 01/06/2005 | US20050004153 inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); use treating transplant rejection, rheumatoid arthritis, diabetes, inflammatory bowel disease, and chronic obstructive pulmonary disease; 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 01/06/2005 | US20050004142 furo(2,3-d)pyrimidine and thieno(2,3-d)pyrimidine compounds for treating cancer and hyperproliferative diseases; receptor tyrosine kinase inhibitors |
| 01/06/2005 | US20050004140 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states |
| 01/06/2005 | US20050004136 Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful as neurokinin receptor modulators |
| 01/06/2005 | US20050004135 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
| 01/06/2005 | US20050004132 Pain, immune diseases, inflammatory disorders; low toxicity; such as 1-[2-(3-(4-Pyridyl)phenyl)ethyl]-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine 1-oxide |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004125 Such as 4-[[4-(1-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]-benzonitrile; bipolar disorder, pain, type 2 diabetes |
| 01/06/2005 | US20050004120 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 01/06/2005 | US20050004116 Triazole inhibitors of type 2 methionine aminopeptidase |
| 01/06/2005 | US20050004115 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004096 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 01/06/2005 | US20050004061 Immunostimulatory nucleic acid molecules |
| 01/06/2005 | US20050004045 Substances for use in treating psoriasis |
| 01/06/2005 | US20050004025 Modulation of acetylcholine receptors; central nervous system disorders; schizophenia; skin disorders; Alzheimer's and Parkinson's disease |
| 01/06/2005 | US20050003446 Peptide sequences for use in identification of modulators for use in treatment and prevention of inflammatory, cell proliferative, arteriosclerotic and skin disorders |
| 01/06/2005 | US20050003353 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/06/2005 | US20050003352 Comprises recombinant mitochondrial transport protein for diagnosis, prevention and treatment of alzheimer's, diabetes, parkinson's, huntington's, cancers |
| 01/06/2005 | US20050003031 Anti-cancer compounds |
| 01/06/2005 | US20050003023 Topical composition for the treatment of psoriasis and related skin disorders |
| 01/06/2005 | US20050002974 Itch-relieving cosmetic or dermatological preparation |